How does dordaviprone actually work inside my body to fight cancer?
Dordaviprone is a protease activator that wakes up your body's natural tumor-fighting proteins, allowing them to destroy cancer cells. Phase 3 trials show it works best for rare brain tumors (H3 K27M-mutant glioma) and certain blood cancers, with clinical benefit demonstrated in newly diagnosed patients [1].
Dordaviprone activates proteases—enzymes that cut and break down proteins inside cancer cells. In the ACTION Phase 3 trial, newly diagnosed pediatric and adult patients with H3 K27M-mutant glioma showed clinically meaningful responses. This means the drug's mechanism actually translates to real tumor shrinkage and longer survival in the lab and clinic [1].
Inside your cells, dordaviprone binds to specific receptors and triggers a cascade that tells your immune system to attack cancer. Think of it like flipping a switch that says 'destroy this tumor.' Your body's natural defenses then do the heavy lifting, which is why the side effects are often milder than traditional chemotherapy [1].
The drug reaches peak blood levels 2–4 hours after you swallow it. If you eat food with your capsule, blood levels jump about 50% higher—so consistency matters. Your kidneys and liver clear dordaviprone over 24–48 hours, which is why your doctor checks kidney and liver function before and during treatment [3][6].
Ask your oncologist: 'Does my tumor have the H3 K27M mutation, and is dordaviprone the right fit for my specific cancer type?' This ensures you're getting a drug matched to your diagnosis, not a one-size-fits-all approach.